Wada Koichiro, Uehara Shinya, Kira Shinichiro, Matsumoto Masahiro, Sho Takehiko, Kurimura Yuichiro, Hashimoto Jiro, Uehara Teruhisa, Yamane Takashi, Kanamaru Sojun, Togo Yoshikazu, Taoka Rikiya, Takahashi Akira, Yamada Yusuke, Yokomizo Akira, Yasuda Mitsuru, Tanaka Kazushi, Hamasuna Ryoichi, Takahashi Satoshi, Hayami Hiroshi, Watanabe Toyohiko, Monden Koichi, Kiyota Hiroshi, Deguchi Takashi, Naito Seiji, Tsukamoto Taiji, Arakawa Soichi, Fujisawa Masato, Yamamoto Shingo, Kumon Hiromi, Matsumoto Tetsuro
Nihon Hinyokika Gakkai Zasshi. 2013 May;104(3):505-12. doi: 10.5980/jpnjurol.104.505.
The "Japanese guidelines for prevention of perioperative infections in urological field" was edited by the Japanese Urological Association in 2007. They are the first Japanese guidelines for antimicrobial prophylaxis specifically to prevent perioperative infections in the urological field. We report here the results of a multicenter prospective study conducted to examine the validity and usefulness of these guidelines.
The subjects were 513 patients who had undergone urological surgeries between July and September 2008 at 10 nationwide university institutions in the Japanese Society of UTI Cooperative Study Group. These surgeries were transurethral resection of bladder (TURBT), transurethral resection of prostate (TURP), adrenalectomy, nephrectomy, nephroureterectomy, radical prostatectomy and total cystectomy. Analysis was performed on patient information, surgical procedures, types and durations of administration of prophylactic antibiotic agents, and the presence of surgical site infections (SSI) and remote infections (RI).
Of 513 patients, 387 (75.4%) were administered prophylactic antibiotic agents according to the guidelines. In these patients, the incidences of SSI and RI were 5.9% and 4.1%, respectively. Multivariate analysis showed that significant factors for SSI were the surgical risk (according to the ASA physical status classification system), diabetes, and operation time, and that the only significant factor for RI was the operation time.
More large-scale study and evidences are necessary in order to demonstrate the validity and usefulness of these guidelines.
《日本泌尿外科领域围手术期感染预防指南》由日本泌尿外科学会于2007年编辑而成。这是日本首部专门针对预防泌尿外科领域围手术期感染的抗菌预防指南。我们在此报告一项多中心前瞻性研究的结果,该研究旨在检验这些指南的有效性和实用性。
研究对象为2008年7月至9月间在日本泌尿道感染合作研究组的10家全国性大学机构接受泌尿外科手术的513例患者。这些手术包括经尿道膀胱肿瘤切除术(TURBT)、经尿道前列腺切除术(TURP)、肾上腺切除术、肾切除术、肾输尿管切除术、根治性前列腺切除术和全膀胱切除术。对患者信息、手术操作、预防性抗生素的使用类型和持续时间,以及手术部位感染(SSI)和远处感染(RI)的情况进行了分析。
513例患者中,387例(75.4%)按照指南使用了预防性抗生素。在这些患者中,SSI和RI的发生率分别为5.9%和4.1%。多因素分析显示,SSI的显著相关因素为手术风险(根据美国麻醉医师协会身体状况分类系统)、糖尿病和手术时间,而RI的唯一显著相关因素是手术时间。
为了证明这些指南的有效性和实用性,需要进行更多大规模的研究并提供更多证据。